Supplementary Materials from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

Mariëtte I.E. van Poelgeest(Leiden University), Sjoerd H. van der Burg(Leiden University Medical Center), Toos Daemen(University Medical Center Groningen), Tjalling Bosse(Leiden University Medical Center), Marjolein J. Kagie(Medisch Centrum Haaglanden), Renee Vermeij(University Medical Center Groningen), Linda F. M. Stynenbosch(Leiden University Medical Center), A. Rob P.M. Valentijn(Leiden University Medical Center), Marc van Beurden(Oncode Institute), J. Hanneke N.G. Oude Elberink, Nikki M. Loof(Leiden University Medical Center), Margriet J.G. Löwik, Bart W.J. Hellebrekers(Haga Hospital), Henk W.R. Schreuder(Gynecologic Oncology Group), Hans W. Nijman(University Medical Center Groningen), Marij J.P. Welters(Leiden University Medical Center), Dorien M.A. Berends-van der Meer, Lorraine M. Fathers(Leiden University Medical Center), Theo Stijnen(Leiden University Medical Center), Gemma G. Kenter(European Organisation for Research and Treatment of Cancer), Edith M.G. van Esch(Leiden University Medical Center), Jaap Oostendorp(Leiden University Medical Center), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), J. Baptist Trimbos(Leiden University), Harry Hollema(University Medical Center Groningen), G. J. Fleuren(Leiden University), Ineke L.E. Hamming(University Medical Center Groningen)

Unknown

March 31, 2023

Cited by 0

|New England Journal of Medicine|2018|1.4k

|Annals of Oncology|2015|1.4k

|British Journal of Cancer|2011|1.3k

|Journal of Clinical Investigation|2015|1.1k

|Cellular and Molecular Immunology|2020|919

Related Papers